Massimo Franchini to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Massimo Franchini has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.122
-
Efficacy and safety of a recombinant factor VIII produced from a human cell line (simoctocog alfa). Expert Opin Drug Saf. 2017 Mar; 16(3):405-410.
Score: 0.122